NAV
$87.47
AUM
$157.9M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.77
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +9.49% | +3.43% | +5.72% | +22.19% | +19.53% | +8.52% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | HSBA.L | HSBC Holdings PLC | 3.18% |
| 2 | 6857.T | Advantest Corp | 2.98% |
| 3 | ASML.AS | ASML Holding NV | 2.24% |
| 4 | NOVN.SW | Novartis AG Registered Shares | 2.09% |
| 5 | SHEL.L | Shell PLC | 2.07% |
| 6 | ABBN.SW | ABB Ltd | 1.97% |
| 7 | UBSG.SW | UBS Group AG Registered Shares | 1.86% |
| 8 | TTE.PA | TotalEnergies SE | 1.81% |
| 9 | BARC.L | Barclays PLC | 1.77% |
| 10 | BBVA.MC | Banco Bilbao Vizcaya Argentaria SA | 1.68% |
The fund will seek to achieve its investment objective by investing at least 80% of its net assets in a portfolio of equity securities of developed market companies, including through investments in common stock, depositary receipts, and common and preferred shares of real estate investment trusts ("REITs"), and forward foreign currency exchange contracts and currency spot transactions used to hedge the fund's exposure to the currencies in which the equity securities of such developed market companies are denominated.
Inception Date: 2016-04-13